意大利克雷马医院重症监护治疗重症SARS-CoV-2感染患者的经验
意大利克雷马医院2020年疫情开始至6月底连续纳入54例因SARS-CoV-2相关严重急性呼吸感染和ARDS入住ICU的患者,入院标准基于难治性低氧、一般状况和临床损害、合并症及CT影像。患者从急诊到ICU平均约120小时,ICU平均住院28天,男性居多,60-69岁组最多,共死亡21例,死亡者平均年龄约67岁、存活者约59岁。存活者入ICU时氧饱和度和血气分析平均值更好、D-二聚体平均剂量更低;31例出现ARDS恶化;早期插管25例中死亡9例,无创通气24小时后插管23例中死亡12例;17/28例存在多重合并症,为额外不良预后因素;呼吸恶化后肾功能衰竭最常见(16例)。全部患者接受经验性或目标性抗生素治疗及低分子肝素治疗,多数接受抗病毒药物和羟氯喹的超说明书方案,使用可的松支持治疗并监测,3例使用抗IL-6单克隆抗体(托珠单抗)。
要点
- 连续54例SARS-CoV-2相关ARDS入住ICU患者中死亡21例,死亡者平均年龄约67岁 vs 存活者约59岁。
- 早期插管25例中死亡9例,无创通气24小时后插管23例中死亡12例。
- 存活者入ICU时氧饱和度和血气分析平均 values 优于死亡者,D-二聚体平均剂量低于死亡者。
- 17/28例存在多重合并症,为额外不良预后因素;呼吸恶化后肾功能衰竭最常见(16例)。
- 全部患者接受经验性或目标性抗生素治疗及低分子肝素治疗;多数接受抗病毒药物和羟氯喹超说明书方案,可的松支持治疗并监测,3例使用托珠单抗。
适用人群与场景
- 2020年疫情开始至2020年6月底在克雷马医院急诊科连续纳入的54例入住ICU、因SARS-CoV-2病毒感染导致严重急性呼吸感染(SARI)和严重呼吸窘迫(ARDS)的患者。
- 招募标准基于难治性低氧、一般状况和临床损害、合并症及CT图像。
处置流程与药物剂量
- 全部患者接受经验性或目标性抗生素治疗以预防和控制潜在病原体感染,并联合低分子肝素治疗。
- 多数患者接受抗病毒药物和羟氯喹的超说明书方案。
- 使用可的松支持治疗并在监测下进行。
- 3例使用抗IL-6单克隆抗体(托珠单抗)方案。
- 对严重低氧的SARS-CoV-2患者,保护性通气是必要的治疗;作者认为关键前提是寻找最佳「个体化」值,因为条件可因患者而异,同一患者在不同通气时间也可变化。
红旗征与不能漏的情况
- ARDS恶化:31例出现ARDS恶化。
- 多重合并症:17/28例存在多重合并症,为额外不良预后因素。
- 呼吸恶化后肾功能衰竭:16例。
- 其他并发症:通气所致气压伤机制损伤(VILI)、缺血性心脏病、中枢和外周神经系统事件(感觉改变、脑膜脑炎、脑出血、多神经肌病)。
研究设计与关键结果
- 单中心连续54例入住ICU的SARS-CoV-2相关SARI和ARDS患者;症状出现时间在1-14天范围内;从急诊入院到ICU入院平均约120小时;ICU平均住院28天。
- 男性居多,最显著年龄组为60-69岁;共死亡21例,死亡者平均年龄约67岁 vs 存活者平均年龄约59岁。
- 存活者入ICU时氧饱和度和血气分析平均值更好,D-二聚体平均剂量低于死亡者。
- 全部患者存在双侧肺炎;31例出现ARDS恶化。
- 早期插管25例中死亡9例,无创通气24小时后插管23例中死亡12例;插管患者中21例(均有ARDS恶化)死亡,无创通气患者无死亡。
- 17/28例存在多重合并症;呼吸恶化后肾功能衰竭最常见(16例);并发症还包括气压伤机制损伤、缺血性心脏病、中枢神经系统事件(感觉改变、脑膜脑炎、脑出血)和外周神经事件(多神经肌病)。
- 胸部CT简化分类:死亡者多见3D和2C病变,以重度和中度形式为主;存活者以中度和中度形式为主。
证据类型、等级与局限
- 证据类型:单中心连续病例系列(观察性研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对SARS-CoV-2相关严重低氧患者,保护性通气是必要的治疗;作者认为应寻找最佳「个体化」通气值,因为条件可因患者而异、同一患者在不同通气时间也可变化。
- 作者认为,呼吸综合征的异质性和多重合并症的存在是不良预后因素。
- 作者认为,进一步研究这一异质性病理并共享数据可能有助于确定更 dedicated 的临床决策和治疗路径,结合资源规划可更好地应对任何新的疾病暴发。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: In this work, the survival and mortality data of 54 consecutive patients admitted to the Intensive Care Unit (ICU) and suffering from severe respiratory insufficiency imputable to viral SARS - CoV - 2 infection were analyzed and shared, after a critical review of the evidence in order to optimize the most dedicated clinical and treatment strategy, for a future 'targeted' management in the care of the possible return flu outbreak.
METHODS: At our Emergency Department of the Crema Hospital, from the beginning of the pandemic until the end of June 2020, 54 consecutive patients admitted to ICU suffering from severe acute respiratory infection (SARI) and severe respiratory distress (ARDS) attributable to viral SARS - CoV - 2 infection were recruited. The recruitment criterion was based on refractory hypoxia, general condition and clinical impairment, comorbidities and CT images. The incoming parameters of the blood chemistry and radiology investigations and the timing of the gold - tracheal intubation were compared. Medical therapy was based on the application of shared protocols.
RESULTS: The onset of symptoms was varyng, i.e. within the range of 1-14 days. The average time from the admission to the emergency room to the admission to intensive care was approximately 120 h. The average number of days of hospitalization in the ICU was 28 days. With a majority of male patients, the most significant age group was between 60 and 69 years. There were 21 deaths and, compared to the survivors, the deceased ones were older at an average age of about 67 years (vs an average age of the survivors of about 59 years). From the available data entering the ICU, the surviving patients presented average better values of oximetry and blood gas analysis, with a lower average dosage of D-Dimer than the deceased. Ones with a presence of bilateral pneumonia in all patients, the worsening of the ARDS occurred in 31 patients. 9 out of 25 patients early intubated died, while 12 out of 23 patients died when intubation was performed after 24 h of non-invasive ventilation. The presence of multiple comorbidities was shown in 17 of 28 patients and revealed an additional adverse prognostic factor. Also, more than one complication in the same patient were detected; after respiratory worsening, renal failure was more frequently found in 16 patients. Some particular complications such as lesions induced by ventilation with barotrauma mechanism (VILI), ischemic heart disease and the appearance of central and peripheral neurological events were detected too.
CONSIDERATIONS: SARS - CoV - 2 disease is caused by a new coronavirus that has its main route of transmission through respiratory droplets and close contact, resulting in a sudden onset of the clinical syndrome with acute respiratory infection (SARI) and severe respiratory distress (ARDS). But it can also appear with other symptoms such as gastrointestinal or neurological events, as to be considered as a disease with multisystem phenotype. This pathology evolves towards a serious form of systemic disease from an acute lung damage to venous and arterial thromboembolic complications and multi-organ failure, mostly associated with high mortality. All patients received empirical or targeted antibiotic therapy for prevention and control of infections of potential pathogens, together with low molecular weight heparin therapy. The majority of patients was subjected to the off - label protocol with antivirals and hydroxychloroquine therapy, we used cortisone support therapy under surveillance and in 3 cases the protocol with anti - IL6 monoclonal antibody (Tolicizumab). In a simplified classification of the tomographic examination of the chest, mostly 3D and 2C lesions were found in the deceased patients with a prevalence of severe and moderate forms, whilst in the survivors the distribution appears with a prevalence of medium and moderate forms. Among the intubated patients, 21 patients, all suffering from worsening ARDS, died whilst there was no mortality in patients subjected to non-invasive ventilation it so. The heterogeneity of the respiratory syndromes and the presence of multiple comorbidities represent an unfortunate prognostic factor. Among the complications, besides the respiratory worsening, renal failure, liver failure and the state of sepsis were most frequently found; less frequent complications were lesions induced by ventilation with a barotrauma mechanism, ischemic heart disease, the appearance of central neurological events of sensory alterations, meningo - encephalitis and cerebral hemorrhage, and peripheral neurological events with polyneuro - myopathies. Mechanical ventilation can adversely affect the prognosis due to lung damage induced, protective ventilation remains the necessary treatment during severe hypoxia in patients with SARS - CoV - 2. The essential prerequisite remains the search for optimal 'customized' values since conditions can vary from patient to patient and, in the same patient, during different times of ventilation.
CONCLUSIONS: In these extraordinary circumstances, our reality was among the most affected and was able to hold the impact thanks to the immediate great response set in place by the operators, although it costed us an effort especially the one to try to guarantee a high quality level of assistance and care compared to the huge wave of patients in seriously bad conditions. Further research on this heterogeneous pathology and data sharing could help identify a more dedicated clinical decision-making and treatment pathway that, together with a resource planning, would allow us to better face any new disease outbreak.
参考来源
- Zuccon W, Comassi P, Adriani L, et al. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy. Am J Emerg Med. 2020. PMID: 33046317. doi:10.1016/j.ajem.2020.08.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。